Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CASP2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDLIM1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HCST - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SZRD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HMGN4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LOC101927157 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
STK17A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MIR636 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TMCO1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NEIL3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
VAMP3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MED22 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MAPKAPK2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KIDINS220 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NFE2L3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ATP5B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DNAJC13 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SHC1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CASP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on